[1]
A. Pednekar, A. Gupta, and S. Warrier, “The MeViDa Study: Bioequivalence Study of FDC of Dapagliflozin, Vildagliptin SR and Metformin SR in Healthy Indian Volunteers: A Randomized, Open-Label, Crossover Study”, J. Drug Delivery Ther., vol. 14, no. 7, pp. 1–5, Jul. 2024, doi: 10.22270/jddt.v14i7.6674.